Dopamine transporter knockout mice
    31.
    发明授权
    Dopamine transporter knockout mice 失效
    多巴胺转运蛋白敲除小鼠

    公开(公告)号:US5866756A

    公开(公告)日:1999-02-02

    申请号:US724405

    申请日:1996-10-02

    摘要: A recombinant rodent comprises cells containing a pair of genomic dopamine transporter protein alleles, wherein at least one of said alleles is incapable of expressing endogenous dopamine transporter protein. The rodent may be a homozygote, where both of said alleles are incapable of expressing endogenous dopamine transporter protein, or the rodent may be a heterozygote, and one of said alleles expresses endogenous dopamine transporter protein. The rodent is preferably a mouse.

    摘要翻译: 重组啮齿动物包含含有一对基因组多巴胺转运蛋白等位基因的细胞,其中所述等位基因中的至少一个不能表达内源性多巴胺转运蛋白。 啮齿动物可以是纯合子,其中两个所述等位基因都不能表达内源性多巴胺转运蛋白,或者啮齿动物可以是杂合子,并且所述等位基因之一表达内源性多巴胺转运蛋白。 啮齿动物优选是小鼠。

    Methods for identifying compounds that regulate beta-arrestin signaling complexes
    32.
    发明授权
    Methods for identifying compounds that regulate beta-arrestin signaling complexes 有权
    鉴定调节β-抑制蛋白信号复合物的化合物的方法

    公开(公告)号:US07999075B2

    公开(公告)日:2011-08-16

    申请号:US12816764

    申请日:2010-06-16

    CPC分类号: G01N33/74 G01N2333/726

    摘要: A method of screening a candidate compound for βArrestin mediated anti-G protein coupled receptor signaling activity is comprises: (a) contacting said candidate compound to a βArrestin signaling complex or a constituent thereof, under conditions in which a signaling complex is formed; and then (b) detecting the presence or absence of disruption of said signaling complex, disruption of said complex indicating said compound has βArrestin mediated anti-G protein coupled receptor signaling activity. Compositions and kits for carrying out the method are also described.

    摘要翻译: 一种筛选候选化合物以控制Arrestin介导的抗G蛋白偶联受体信号传导活性的方法包括:(a)在信号传导复合体是在其下的条件下将所述候选化合物与一种Arrestin信号传导复合物或其组分接触 形成 然后(b)检测所述信号复合物的破坏的存在或不存在,指示所述化合物的所述复合物的破坏具有Arrestin介导的抗G蛋白偶联受体信号传导活性。 还描述了用于实施该方法的组合物和试剂盒。

    METHODS FOR IDENTIFYING COMPOUNDS THAT REGULATE BETA-ARRESTIN SIGNALING COMPLEXES
    33.
    发明申请
    METHODS FOR IDENTIFYING COMPOUNDS THAT REGULATE BETA-ARRESTIN SIGNALING COMPLEXES 有权
    用于鉴定化合物的方法,所述化合物调节β-阿霉素信号复合物

    公开(公告)号:US20100255498A1

    公开(公告)日:2010-10-07

    申请号:US12816764

    申请日:2010-06-16

    CPC分类号: G01N33/74 G01N2333/726

    摘要: A method of screening a candidate compound for βArrestin mediated anti-G protein coupled receptor signaling activity is comprises: (a) contacting said candidate compound to a βArrestin signaling complex or a constituent thereof, under conditions in which a signaling complex is formed; and then (b) detecting the presence or absence of disruption of said signaling complex, disruption of said complex indicating said compound has βArrestin mediated anti-G protein coupled receptor signaling activity. Compositions and kits for carrying out the method are also described.

    摘要翻译: 一种筛选候选化合物以控制Arrestin介导的抗G蛋白偶联受体信号传导活性的方法包括:(a)在信号传导复合体是在其下的条件下将所述候选化合物与一种Arrestin信号传导复合物或其组分接触 形成 然后(b)检测所述信号复合物的破坏的存在或不存在,指示所述化合物的所述复合物的破坏具有Arrestin介导的抗G蛋白偶联受体信号传导活性。 还描述了用于实施该方法的组合物和试剂盒。

    Modified G-protein coupled receptors
    36.
    发明授权
    Modified G-protein coupled receptors 有权
    修饰的G蛋白偶联受体

    公开(公告)号:US07214496B2

    公开(公告)日:2007-05-08

    申请号:US11026435

    申请日:2004-12-30

    IPC分类号: G01N33/53

    CPC分类号: C07K14/705

    摘要: The present invention relates to modified G-protein coupled receptors (GPCRs). The modified GPCRs of the present invention include GPCRs that have been modified to have carboxyl terminal tails comprising one or more sites of phosphorylation, preferably one or more clusters of phosphorylation sites. The modified GPCRs of the present invention may comprise a retained portion of a carboxyl-terminus region from a first GPCR fused to a polypeptide, wherein the polypeptide comprises the one or more clusters of phosphorylation. The present invention also relates to methods of screening compounds and sample solutions for GPCR activity using the modified GPCRs.

    摘要翻译: 本发明涉及修饰的G蛋白偶联受体(GPCR)。 本发明的修饰的GPCR包括已被修饰为具有包含一个或多个磷酸化位点的羧基末端尾,优选一个或多个磷酸化位点簇的GPCR。 本发明的修饰的GPCR可以包含与多肽融合的第一GPCR的羧基末端区域的保留部分,其中多肽包含一个或多个磷酸化簇。 本发明还涉及使用修饰的GPCR筛选化合物和GPCR活性的样品溶液的方法。

    High affinity L-proline transporter polypeptides; antibodies and
immunoassays specific for them
    38.
    发明授权
    High affinity L-proline transporter polypeptides; antibodies and immunoassays specific for them 失效
    高亲和力L-脯氨酸转运蛋白多肽; 针对他们的抗体和免疫测定

    公开(公告)号:US5759788A

    公开(公告)日:1998-06-02

    申请号:US753985

    申请日:1996-12-03

    摘要: The anatomical distribution, nucleic acid sequence, pharmacological properties, and inferred structural features of a cDNA encoding a high affinity, Na.sup.+ -dependent rat brain L-proline transporter is described. The expression of this carrier in subpopulations of putative glutamatergic pathways supports a specific role for L-proline in excitatory amino acid neurotransmission. The cloned transporter cDNA predicts a 637 amino acid protein with 12 putative transmembrane domains and exhibits 44%-45% amino acid sequence identity with other neurotransmitter transporters. These findings support a synaptic role for L-proline in specific excitatory pathways in the CNS. The sequence can be used for expression of the transporter molecule, to make probes for the same protein from other species and related proteins, in diagnostic assays, and to design functional and structural analogs for use in research and possible clinical treatments. The protein is useful in making antibodies, conducting research studies, and design of therapeutic transporter modulators for clinical treatments.

    摘要翻译: 描述了编码高亲和力,Na +依赖性大鼠脑L-脯氨酸转运蛋白的cDNA的解剖分布,核酸序列,药理学性质和推断的结构特征。 该载体在推定的谷氨酸能途径的亚群中的表达支持L-脯氨酸在兴奋性氨基酸神经传递中的特异性作用。 克隆的转运蛋白cDNA预测具有12个推定的跨膜结构域的637个氨基酸的蛋白质,并且与其他神经递质转运体显示44%-45%的氨基酸序列同一性。 这些发现支持L-脯氨酸在CNS中特异性兴奋途径中的突触作用。 该序列可用于表达转运蛋白分子,在诊断测定中制备来自其他物种和相关蛋白质的相同蛋白质的探针,并设计用于研究和可能的临床治疗的功能和结构类似物。 该蛋白质可用于制备抗体,进行研究和设计用于临床治疗的治疗性转运蛋白调节剂。

    High affinity, brain-specific nucleic acids encoding a L-proline
transporter, and vectors, and host cells comprising the same
    39.
    发明授权
    High affinity, brain-specific nucleic acids encoding a L-proline transporter, and vectors, and host cells comprising the same 失效
    编码L-脯氨酸转运蛋白的高亲和性,脑特异性核酸,和载体,以及包含其的宿主细胞

    公开(公告)号:US5580775A

    公开(公告)日:1996-12-03

    申请号:US879617

    申请日:1992-05-01

    摘要: The anatomical distribution, nucleic acid sequence, pharmacological properties, and inferred structural features of a cDNA encoding a high affinity, Na.sup.+ -dependent rat brain L-proline transporter is described. The expression of this carrier in subpopulations of putative glutamatergic pathways supports a specific role for L-proline in excitatory amino acid neurotransmission. The cloned transporter cDNA predicts a 637 amino acid protein with 12 putative transmembrane domains and exhibits 44%-45% amino acid sequence identity with other neurotransmitter transporters. These findings support a synaptic role for L-proline in specific excitatory pathways in the CNS. The sequence can be used for expression of the transporter molecule, to make probes for the same protein from other species and related proteins, in diagnostic assays, and to design functional and structural analogs for use in research and possible clinical treatments. The protein is useful in making antibodies, conducting research studies, and design of therapeutic transporter modulators for clinical treatments.

    摘要翻译: 描述了编码高亲和力,Na +依赖性大鼠脑L-脯氨酸转运蛋白的cDNA的解剖分布,核酸序列,药理学性质和推断的结构特征。 该载体在推定的谷氨酸能途径的亚群中的表达支持L-脯氨酸在兴奋性氨基酸神经传递中的特异性作用。 克隆的转运蛋白cDNA预测具有12个推定的跨膜结构域的637个氨基酸的蛋白质,并且与其他神经递质转运体显示44%-45%的氨基酸序列同一性。 这些发现支持L-脯氨酸在CNS的特异性兴奋途径中的突触作用。 该序列可用于表达转运蛋白分子,在诊断测定中制备来自其他物种和相关蛋白质的相同蛋白质的探针,并设计用于研究和可能的临床治疗的功能和结构类似物。 该蛋白质可用于制备抗体,进行研究和设计用于临床治疗的治疗性转运蛋白调节剂。

    Cloned genes encoding the D.sub.1 dopamine receptor
    40.
    发明授权
    Cloned genes encoding the D.sub.1 dopamine receptor 失效
    编码D1多巴胺受体的克隆基因

    公开(公告)号:US5389543A

    公开(公告)日:1995-02-14

    申请号:US908654

    申请日:1992-07-02

    摘要: Cloned genes which code for the D.sub.1 dopamine receptor are disclosed. The receptors coded for by these clones bind dopamine ligands with the proper pharmacological profile and, when expressed in the cell membrane of a suitable host and so bound, stimulate adenylyl cyclase. Also disclosed are vectors comprising a cloned gene encoding a D.sub.1 -dopamine receptor, cells transformed with such vectors, and oligonucleotide probes capable of selectively hybridizing to DNA comprising a portion of a gene coding for a D.sub.1 -dopamine receptor. The cloned genes are useful for making proteins and cell membrane preparations which can be used to screen compounds for D.sub.1 -dopamine receptor binding activity, are useful in molecular biology, and are useful as diagnostic probes.

    摘要翻译: 公开了编码D1多巴胺受体的克隆基因。 由这些克隆编码的受体结合具有适当药理学特征的多巴胺配体,并且当在合适的宿主的细胞膜中表达并如此结合时,刺激腺苷酸环化酶。 还公开了包含编码D1-多巴胺受体的克隆基因,用这些载体转化的细胞和能够与包含编码D1-多巴胺受体的基因的一部分的DNA选择性杂交的寡核苷酸探针的载体。 克隆的基因可用于制备可用于筛选化合物的多巴胺受体结合活性的蛋白质和细胞膜制剂,可用于分子生物学,并且可用作诊断探针。